Teva Pharmaceutical Industries (TEVA) Change in Cash (2017 - 2025)
Historic Change in Cash for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $1.4 billion.
- Teva Pharmaceutical Industries' Change in Cash rose 761666.67% to $1.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $256.0 million, marking a year-over-year increase of 24594.59%. This contributed to the annual value of $256.0 million for FY2025, which is 24594.59% up from last year.
- As of Q4 2025, Teva Pharmaceutical Industries' Change in Cash stood at $1.4 billion, which was up 761666.67% from $42.0 million recorded in Q3 2025.
- Teva Pharmaceutical Industries' Change in Cash's 5-year high stood at $1.4 billion during Q4 2025, with a 5-year trough of -$1.6 billion in Q1 2025.
- Over the past 5 years, Teva Pharmaceutical Industries' median Change in Cash value was $47.0 million (recorded in 2022), while the average stood at $69.0 million.
- In the last 5 years, Teva Pharmaceutical Industries' Change in Cash crashed by 136538.46% in 2023 and then soared by 761666.67% in 2025.
- Over the past 5 years, Teva Pharmaceutical Industries' Change in Cash (Quarter) stood at $153.0 million in 2021, then soared by 276.47% to $576.0 million in 2022, then soared by 69.62% to $977.0 million in 2023, then tumbled by 101.84% to -$18.0 million in 2024, then surged by 7616.67% to $1.4 billion in 2025.
- Its Change in Cash was $1.4 billion in Q4 2025, compared to $42.0 million in Q3 2025 and $464.0 million in Q2 2025.